We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Guangzhou Pluslife Biotech Co., Ltd.

EUROIMMUN AG

  Silver Produces reagents for medical laboratory diagnostics, including test systems for the determination of various antibod... read more Featured Products: More products

Download Mobile App





Euroimmun Presents New EUROArray Dermatomycosis Assay at Lab Fair

By LabMedica International staff writers
Posted on 31 Jan 2019
Print article
Image: The EUROArray Dermatomycosis assay (Photo courtesy of Euroimmun).
Image: The EUROArray Dermatomycosis assay (Photo courtesy of Euroimmun).
Euroimmun (Lübeck, Germany) presented its new EUROArray Dermatomycosis assay at MedLab Middle East 2019, an international platform for laboratory management and medicine held from February 4-7, 2019, in Dubai, UAE. MedLab is the only medical laboratory industry event that offers manufacturers the opportunity to meet a diverse audience of buyers. From distributors to senior end-users, the 2019 edition welcomed over 19,610 medical lab and trade professionals in search of the latest innovations.

At at MedLab Middle East 2019, Euroimmun presented its new EUROArray Dermatomycosis assay, which provides direct detection and differentiation of the most important dermatomycosis pathogens in one test. The assay simultaneously detects 50 dermatophyte species, and provides species identification for 23 of these as well as for six yeasts and moulds. Accurate identification of the disease-causing pathogens enables early, targeted treatment, increasing the chances of therapy success.

The DNA microarray offers an enormous time advantage over classical detection methods such as pathogen culturing and microscopy, taking just three hours rather than weeks. It is particularly useful for detecting dermatophytes that are difficult to cultivate or those that are slow growing and thus likely to be overlooked. The test specifically identifies mixed infections, for example with yeasts and moulds, and aids differentiation of dermatomycoses from other dermatoses such as psoriasis. Moreover, the assay provides high sensitivity even in patients already undergoing therapy.

The EUROArray procedure is extremely easy to perform and does not require in-depth molecular biology knowledge. Ready-to-use reagents and the small number of pipetting steps ensure a minimal workload. The evaluation and interpretation of results as well as the archiving of data are fully automated and thus, objective. The EUROArray Dermatomycosis provides the most comprehensive direct detection of dermatomycosis pathogens currently available commercially, and thus represents a valuable new tool for dermatologists.

Gold Supplier
Microplate Centrifuge & Reader
Lyra MP-Reader II
New
Hemolysing Reagent
Dialyse-BA 5D
New
Dengue Real-Time RT-PCR Test
Simplexa Dengue Kit
New
Automated Clinical Chemistry Analyzer
DRI-CHEM NX600

Print article
SUGENTECH INC.

Channels

Clinical Chem.

view channel
Image: ELISA kit for liver-type fatty acid–binding protein (L-FABP). The level of L-FABP present in urine reflects the level of renal tubular dysfunction (Photo courtesy of Sekisui Medical Co)

Urinary Biomarkers Predict Weaning From Acute Dialysis Therapy

Acute kidney injury is associated with a higher risk of chronic kidney disease (CKD), end-stage renal disease, and long-term adverse cardiovascular effects. Critically ill patients with acute kidney injury... Read more

Microbiology

view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more

Pathology

view channel
Image: Breast cancer spread uncovered by new molecular microscopy (Photo courtesy of Wellcome Sanger Institute)

New Molecular Microscopy Tool Uncovers Breast Cancer Spread

Breast cancer commonly starts when cells start to grow uncontrollably, often due to mutations in the cells. Overtime the tumor becomes a patchwork of cells, called cancer clones, each with different mutations.... Read more

Industry

view channel
Image: With Cell IDx’s acquisition, Leica Biosystems will be moving its multiplexing menu forward (Photo courtesy of Leica Biosystems)

Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling

Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.